Correlation Between Egetis Therapeutics and Simris Alg

Can any of the company-specific risk be diversified away by investing in both Egetis Therapeutics and Simris Alg at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Egetis Therapeutics and Simris Alg into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Egetis Therapeutics AB and Simris Alg AB, you can compare the effects of market volatilities on Egetis Therapeutics and Simris Alg and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Egetis Therapeutics with a short position of Simris Alg. Check out your portfolio center. Please also check ongoing floating volatility patterns of Egetis Therapeutics and Simris Alg.

Diversification Opportunities for Egetis Therapeutics and Simris Alg

-0.04

Correlation Coefficient

Egetis Therapeutics  Simris Alg

Good diversification

The 3 months correlation between Egetis and Simris is -0.04. Overlapping area represents the amount of risk that can be diversified away by holding Egetis Therapeutics AB and Simris Alg AB in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Simris Alg AB and Egetis Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Egetis Therapeutics AB are associated (or correlated) with Simris Alg. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Simris Alg AB has no effect on the direction of Egetis Therapeutics i.e., Egetis Therapeutics and Simris Alg go up and down completely randomly.

Pair Corralation between Egetis Therapeutics and Simris Alg

Assuming the 90 days trading horizon Egetis Therapeutics AB is expected to generate 0.52 times more return on investment than Simris Alg. However, Egetis Therapeutics AB is 1.93 times less risky than Simris Alg. It trades about 0.02 of its potential returns per unit of risk. Simris Alg AB is currently generating about -0.05 per unit of risk. If you would invest  568.00  in Egetis Therapeutics AB on September 3, 2024 and sell it today you would lose (7.00) from holding Egetis Therapeutics AB or give up 1.23% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Egetis Therapeutics AB  vs.  Simris Alg AB

Egetis Therapeutics

Risk-Adjusted Performance

1 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Egetis Therapeutics AB are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively stable basic indicators, Egetis Therapeutics is not utilizing all of its potentials. The current stock price uproar, may contribute to short-horizon losses for the private investors.

Simris Alg AB

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Simris Alg AB has generated negative risk-adjusted returns adding no value to investors with long positions. Despite uncertain performance in the last few months, the Stock's forward indicators remain somewhat strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Pair Trading with Egetis Therapeutics and Simris Alg

The main advantage of trading using opposite Egetis Therapeutics and Simris Alg positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Egetis Therapeutics position performs unexpectedly, Simris Alg can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Simris Alg will offset losses from the drop in Simris Alg's long position.

The idea behind Egetis Therapeutics AB and Simris Alg AB pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.